株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のにきび市場

Global Acne Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 318282
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界のにきび市場 Global Acne Market 2014-2018
出版日: 2014年11月05日 ページ情報: 英文 72 Pages
概要

にきびは、よく見られる皮膚疾患の1つです。にきび(尋常性座瘡)は、皮膚の炎症性疾患で、ほとんどの年齢層に影響を与えます。にきびの正確な病因は、十分解明されていません。にきびは、健康にとって重大な脅威ではありませんが、重症のにきびでは、痛みを伴うだけでなく、患者の生活の質(QOL)にも影響を与えます。にきびで利用可能な治療薬の選択肢として、局所薬、経口薬、またはすべての組み合わせが挙げられます。世界のにきび市場は、2013年〜2018年のCAGRで、4.07%の成長が見込まれています

当レポートでは、世界のにきび市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測

第7章 にきびの意味

  • ファイブフォース分析

第8章 にきびの種類と特徴

第9章 上市製品の競合評価

第10章 発症率と患者数

  • 米国
  • 英国

第11章 市場区分:カテゴリー別

第12章 地域区分

第13章 購入基準

第14章 市場成長促進要因

第15章 促進要因とその影響

第16章 市場の課題

第17章 促進要因と課題の影響

第18章 市場動向

第19章 動向とその影響

第20章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第21章 主要ベンダーの分析

  • Actavis plc
  • Allergan Inc.
  • Galderma
  • Stiefel Laboratories
  • Valeant Pharmaceuticals International Inc.

第22章 関連レポート

図表

目次
Product Code: IRTNTR4570

About Acne

Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a patient's quality of life. Topical medications, oral medications, or a combination of all are some of the treatment options available for acne.

TechNavio's analysts forecast the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018.

Covered in this Report

The Global Acne market can be divided into seven segments: Antibiotics, Anti-Inflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report covers the present scenario and the growth prospects of the Global Acne market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.

TechNavio's report, the Global Acne Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Acne market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Actavis
  • Allergen
  • Galderma
  • Stiefel Laboratories
  • Valeant Pharmaceuticals International

Other Prominent Vendors

  • Andro Science
  • Bayer
  • Cipher Pharmaceuticals
  • Cosmo Pharmaceuticals
  • Elorac
  • Foamix Pharmaceuticals
  • Helix BioMedix
  • Hygeia Therapeutics
  • IMTM
  • J&J
  • Mylan Pharmaceuticals
  • NanoBio
  • NovaLead Pharma
  • F. Hoffmann-La Roche

Market Driver

  • Significant Unmet Needs
  • For a full, detailed list, view our report

Market Challenge

  • High Cost of Acne Drugs
  • For a full, detailed list, view our report

Market Trend

  • Increased Focus on Combination Therapies
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast

07. Implications of Acne

  • 07.1. Five Forces Analysis

08. Types and Characteristics of Acne

09. Competitive Assessment of Marketed Products

10. Rate of Incidence and Prevalence

    • 10.1.1. US
    • 10.1.2. UK

11. Market Segmentation by Category

12. Geographical Segmentation

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
    • 20.1.2. Mergers and Acquisitions
  • 20.2. Market Share Analysis 2013
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. Actavis plc
    • 21.1.1. Key Facts
    • 21.1.2. Business Description
    • 21.1.3. Business Segmentation
    • 21.1.4. Business Segmentation by Revenue 2012 and 2013
    • 21.1.5. Sales by Geography
    • 21.1.6. Business Strategy
    • 21.1.7. Key Information
    • 21.1.8. SWOT Analysis
  • 21.2. Allergan Inc.
    • 21.2.1. Key Facts
    • 21.2.2. Business Description
    • 21.2.3. Business Segmentation
    • 21.2.4. Revenue by Business Segmentation
    • 21.2.5. Revenue Comparison 2011-2013
    • 21.2.6. Revenue by Geographical Segmentation
    • 21.2.7. Business Strategy
    • 21.2.8. Key Developments
    • 21.2.9. SWOT Analysis
  • 21.3. Galderma
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Product Segmentation by Revenue 2013
    • 21.3.4. Geographical Segmentation by Revenue 2013
    • 21.3.5. Business Strategy
    • 21.3.6. Recent Developments
    • 21.3.7. SWOT Analysis
  • 21.4. Stiefel Laboratories
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Product Segmentation
    • 21.4.4. Geographical Segmentation by Revenue 2013
    • 21.4.5. Business Strategy
    • 21.4.6. Recent Developments
    • 21.4.7. SWOT Analysis
  • 21.5. Valeant Pharmaceuticals International Inc.
    • 21.5.1. Key Facts
    • 21.5.2. Business Overview
    • 21.5.3. Business Segmentation by Revenue 2013
    • 21.5.4. Business Segmentation by Revenue 2012 and 2013
    • 21.5.5. Sales by Geography
    • 21.5.6. Business Strategy
    • 21.5.7. Key Developments
  • 21.6. SWOT Analysis

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Acne Market 2013-2018 (US$ billion)
  • Exhibit 4: Global Acne Market Segmentation by Category
  • Exhibit 5: Global Acne Market by Geographical Segmentation 2013
  • Exhibit 6: Allergen Sales by Portfolio 2012
  • Exhibit 7: Galderma Sales by Therapeutic Area 2012
  • Exhibit 8: Global Acne marketBusiness Segmentation 2013
  • Exhibit 9: Global Acne market Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 10: Actavis Plc: Sales by Geography (in US$ million)
  • Exhibit 11: Allergan Inc.: Business Segmentation
  • Exhibit 12: Allergan Inc.: Revenue by Business Segmentation 2013
  • Exhibit 13: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
  • Exhibit 14: Allergan Inc.: Revenue by Geographical Segmentation 2013
  • Exhibit 15: Galderma: Product Segmentation by Revenue 2013
  • Exhibit 16: Galderma: Geographical Segmentation by Revenue 2013
  • Exhibit 17: Stiefel Laboratories: Product Segmentation 2013
  • Exhibit 18: Stiefel Laboratories: Geographical Segmentation by Revenue 2013
  • Exhibit 19: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2013
  • Exhibit 20: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 21: Valeant Pharmaceuticals International Inc.: Sales by Geography 2013
Back to Top